Ghent University Academic Bibliography

Your filters: cql: author="Maspero, Jorge F" or (type any "bookEditor issueEditor" and editor="Maspero, Jorge F")

Add to list
- Journal Article
- A1
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study

Michael E Wechsler, Linda B Ford, Jorge F Maspero, Ian D Pavord, Alberto Papi, Arnaud Bourdin, Henrik Watz, Mario Castro, Natalia M Nenasheva, Yuji Tohda, et al.

(2022) LANCET RESPIRATORY MEDICINE. 10(1). p.11-25
Add to list
- Journal Article
- A1
- open access
Dupilumab in children with uncontrolled moderate-to-severe asthma

Leonard B Bacharier, Jorge F Maspero, Constance H Katelaris, Alessandro G Fiocchi, Remi Gagnon, Ines de Mir, Neal Jain, Lawrence D Sher, Xuezhou Mao, D. Liu, et al.

(2021) NEW ENGLAND JOURNAL OF MEDICINE. 385(24). p.2230-2240
Add to list
- Conference Paper
- C3
Effect of Dupilumab on patient-reported breathing and rescue medication use

Jonathan Corren, Mario Castro, Jorge F Maspero, William W Busse, Antonio Valero Santiago, Piotr Kuna, Nadia Daizadeh, Nami Pandit-Abid, Benjamin Ortiz, Asif H. Khan, et al.

(2020) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 56(supplement 64).
Add to list
- Journal Article
- A1
- open access
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

William W Busse, Jorge F Maspero, Yufang Lu, Jonathan Corren, Nicola A Hanania, Bradley E Chipps, Constance H Katelaris, J Mark FitzGerald, Santiago Quirce, Linda B Ford, et al.

(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 125(5). p.565-576
Add to list
- Journal Article
- A1
- open access
Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis

Jorge F Maspero, Constance H Katelaris, William W Busse, Mario Castro, Jonathan Corren, Bradley E Chipps, Anju T Peters, Ian D Pavord, Linda B Ford, Lawrence Sher, et al.

(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 8(2). p.527-539
Add to list
- Conference Paper
- C3
Dupilumab consistently improves rhinoconjunctivitis-specific health-related quality of life in patients with uncontrolled, moderate-to-severe asthma and comorbid allergic rhinitis : results from the phase 3 LIBERTY ASTHMA QUEST study

Jean Bousquet, Jorge F Maspero, Bradley E Chipps, Jonathan Corren, J Mark FitzGerald, Zhen Chen, Yufang Lu, Paul Rowe, Heribert Staudinger, Marcella Ruddy, et al.

(2019) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 143(2). p.AB101-AB101
Add to list
- Conference Paper
- C3
- open access
A randomized phase 3 study, SINUS-52, evaluating the efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps

Claus Bachert (UGent) , Martin Desrosiers, Joaquim Mullol, Peter Hellings (UGent) , Anders Cervin, Lawrence Sher, John V Bosso, Stella E Lee, Jorge F Maspero, Shigeharu Fujieda, et al.

(2019) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 143(2, suppl.). p.AB433-AB433
Add to list
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert (UGent) , Joseph K Han, Martin Desrosiers, Peter W Hellings, Nikhil Amin, Stella E Lee, Joaquim Mullol, Leon S Greos, John V Bosso, Tanya M Laidlaw, et al.

(2019) LANCET. 394(10209). p.1638-1650
Add to list
- Journal Article
- A1
- open access
Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases

J Jean Bousquet, Holger J Schunemann, Alkis Togias, Marina Erhola, Peter W Hellings, Torsten Zuberbier, Ioana Agache, Ignacio J Ansotegui, Josep M Anto, Claus Bachert (UGent) , et al.

(2019) CLINICAL AND TRANSLATIONAL ALLERGY. 9(1).
Add to list
- Conference Paper
- C3
Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST

William Busse, Jorge F Maspero, Contance H Katelaris, Dinesh Saralaya, Sophie Guillonneau, Bingzhi Zhang, Christine Taniou, Heribert Staudinger, Jingdong Chao, Nikhil Amin, et al.

(2018) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 52(supplement 62).

Academic Bibliography

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study

Dupilumab in children with uncontrolled moderate-to-severe asthma

Effect of Dupilumab on patient-reported breathing and rescue medication use

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis

Dupilumab consistently improves rhinoconjunctivitis-specific health-related quality of life in patients with uncontrolled, moderate-to-severe asthma and comorbid allergic rhinitis : results from the phase 3 LIBERTY ASTHMA QUEST study

A randomized phase 3 study, SINUS-52, evaluating the efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases

Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST

Contents

Support

Contact